Genomic methods are essential because they enable researchers to identify genetic mutations and alterations that drive cancer progression. Techniques such as Next-Generation Sequencing (NGS) and Polymerase Chain Reaction (PCR) allow for the comprehensive analysis of cancer genomes, helping to pinpoint specific mutations that can be targeted by therapies.